jens juul holst glp 1 Dr. on GLP-1’s Life-Changing Impact on Metabolic Health 專訪唐獎GLP-1 始祖Jens Juul Holst 教授：減重藥物點、線、面，交織成代謝醫學新時代|

The brain: quieting "food noise." GLP-1 receptors in the hypothalamus and reward centers reduce appetite and the intrusive thoughts about food that many patients with obesity describe

This packet offers a transformative approach, focusing on sustainable behavior change and food autonomy

Disclosures: Jane Giang: Nothing to Disclose, Sophia Hurr: Nothing to Disclose, Alfred Barritt IV: Merck (Any division): Advisor, Madrigal: Consultant, Life Edit: Consultant, Boehringer Ingelheim: Consultant, Target-RWE: Consultant 1673 ASSESSING TRANSITIONS OF CARE AMONGST INPATIENTS WITH CIRRHOSIS DISCHARGED FROM A DIVERSE, URBAN LIVER TRANSPLANT CENTER: THE IMPORTANCE OF HEPATOLOGY INVOLVEMENT AND DISCHARGE DESTINATION Max Schechter 1 Katherine Ni 2 Zoe Verzani 3 Kimberline Chew 2 Jang Hyun Kim 2 Lewis Paulino 2 Danielle Garfunkel 2 Lital Aliasi-Sinai 4 Daniel Alvarez 2 Adejoke Johnson 2 Soaptarshi Paul 2 Hamza Sadhra 2 Clara Tow 2 Don Rockey 2 , 1 Albert Einstein College of Medicine, 2 Montefiore Medical Center, 3 Weill Cornell Medicine, 4 American Medical Prgm Tel Aviv Universit Background: Hospitalized patients with cirrhosis are at risk of readmission due to the severity and complexity of their disease

Glucagon-like peptide-1 (GLP-1) receptor agonists: Exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review

1 2 "Setauket scientist Andrew Young's work paves way for drugs like Ozempic"